Novel formulations for treatment of migraine
Abstract
Systems and methods are described for treating un-met medical needs in migraine and related conditions such as cluster headache. Included are treatments that are both rapid onset and long acting, which include sustained release formulations, and combination products. Also included are treatments for multiple symptoms of migraine, especially headache and nausea and vomiting. Systems that are self contained, portable, prefilled, and simple to self administer at the onset of a migraine attack are disclosed, and preferably include a needle-free injector and a high viscosity formulation, to eliminate such issues as fear of self administration with needles, and needle stick and cross contamination.

Term
2.6 yearsto projected expiry
Projected expiry 24 April 2029, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP0546593A1 | Cites | European Patent Office (EPO) | Search report |
| US2005013840A1 | Cites | United States of America | Search report |
| US2006240043A1 | Cites | United States of America | Search report |
| WO2007103113A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| US6586458B1 | Cites | United States of America | Search report |
27 members in 8 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 48463 | United States of America | – | |
| 4846308 | United States of America | P | |
| 09739139 | European Patent Office (EPO) | A | |
| 097391395 | – | – | – |
| 48463 | – | – | – |
| EP20090739139 | – | – | – |
| US20080048463P | – | – | – |
Members27
| Document | Office | Kind | |
|---|---|---|---|
| AU2009241847A1 | Australia | A1 | |
| CA2722743A1 | Canada | A1 | |
| WO2009134336A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP2273880A1 | European Patent Office (EPO) | A1 | |
| CN102014625A | China | A | |
| US2011118189A1 | United States of America | A1 | |
| JP2011518881A | Japan | A | |
| EP2273880A4 | European Patent Office (EPO) | A4 | |
| US2013231311A1 | United States of America | A1 | |
| CN103550847A | China | A | |
| US2014148485A1 | United States of America | A1 | |
| AU2009241847B2 | Australia | B2 | |
| JP2014129365A | Japan | A | |
| EP2756756A1 | European Patent Office (EPO) | A1 | |
| EP2273880B1 | European Patent Office (EPO) | B1 | |
| ES2527448T3 | Spain | T3 | |
| EP2829265A2 | European Patent Office (EPO) | A2 | |
| EP2829265A3This record | European Patent Office (EPO) | A3 | |
| JP2015178496A | Japan | A | |
| EP2756756B1 | European Patent Office (EPO) | B1 | |
| US2016051466A1 | United States of America | A1 | |
| ES2563061T3 | Spain | T3 | |
| EP3000462A1 | European Patent Office (EPO) | A1 | |
| US2016151571A1 | United States of America | A1 | |
| JP5943948B2 | Japan | B2 | |
| EP2829265B1 | European Patent Office (EPO) | B1 | |
| ES2604968T3 | Spain | T3 |
73 legal events, as 10 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Definitive protectionFG2A | FG2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Patent invalid in the netherlands as no translation has been filedMP | MP | NL | |
| Invalidated european patentMG4D | MG4D | LT | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent enters austrian national phase)REF | REF | AT | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Designated contracting statesAK | AK | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Request for examination filed17P | 17P | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2829265
- Publication, DOCDB
- 2829265
- Publication, EPODOC
- EP2829265
- Application
- 141819300
- Application, DOCDB
- 14181930
- Application, EPODOC
- EP20140181930
Titles3
- German
- Neuartige Formulierungen zur Behandlung von Migräne
- English
- Novel formulations for treatment of migraine
- French
- Compositions inédites destinées au traitement de la migraine
Classification
- CPC, 36
- A61M5/30
- A61K9/0019
- A61K9/0021
- A61K31/4045
- A61K9/0024
- A61K31/4178
- A61K9/16
- A61K31/4196
- A61K31/422
- A61K31/44
- A61K31/454
- A61K47/02
- A61K47/10
- A61K47/24
- A61K45/06
- A61K47/26
- A61K47/34
- A61K47/36
- A61P1/02
- A61P1/08
- A61P1/10
- A61P1/12
- A61P1/14
- A61P3/00
- A61P7/00
- A61P9/00
- A61P11/02
- A61P13/02
- A61P21/00
- A61P25/00
- A61P25/04
- A61P25/06
- A61P25/24
- A61P27/02
- A61P29/00
- A61P43/00
- IPC, 3
- A61K9 00
- A01N43 42
- A61K31 44
Designated states35
- Contracting states, 35
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
and 11 moreShow fewer
- North Macedonia
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye